You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) SODIUM


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing SODIUM excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing SODIUM excipient

SODIUM Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Sodium Benzoate Excipients

Introduction to Sodium Benzoate Excipients

Sodium benzoate is a widely used excipient in the pharmaceutical and food industries, serving as a preservative to extend the shelf life of products. Its market dynamics are influenced by a complex interplay of factors, including demand trends, production costs, geopolitical events, and logistical challenges.

Market Demand and Drivers

Seasonal Demand

The demand for sodium benzoate excipients often follows seasonal patterns. For instance, the arrival of spring typically increases the emphasis on food preservation, driving up the demand for preservatives like sodium benzoate[1].

Chronic Diseases and Pharmaceutical Growth

The rise in chronic diseases such as diabetes, hypertension, and cancer has led to an increased need for effective and patient-friendly drug formulations. This has driven the demand for innovative excipients, including sodium benzoate, which enhance the solubility, bioavailability, and stability of active pharmaceutical ingredients (APIs)[3].

Food Sector Demand

In the food sector, the heightened regional offtakes concerning preservatives have contributed to the consistent rise in demand for sodium benzoate excipients. This is particularly notable in the United States, where food preservation practices are more stringent[1].

Production Costs and Supply Chain

Elevated Production Expenses

Higher production expenses in exporting nations, such as China, have resulted in increased costs for the end-product, including sodium benzoate excipients. This is due to a consistent upward trend in the prices of feedstock materials like benzoic acid in previous months[1].

Supply Chain Disruptions

Supply chain disruptions, including transportation bottlenecks and geopolitical tensions, have exacerbated significant challenges in the supply of sodium benzoate excipients. Events like the collapse of a bridge in Baltimore and increased shipping costs due to conflicts in West Asia have further complicated the logistics[1].

Climatic Challenges

Climatic conditions, such as warm and arid spring weather and reduced winter snowpack, pose obstacles to critical transportation routes like the Mississippi River. These challenges compound the complexity of the market landscape, potentially affecting the supply chain and contributing to anticipated price increases[1].

Financial Trajectory

Current Market Value

The pharmaceutical excipients market, which includes sodium benzoate, is valued at USD 972.9 million in 2024. This market is expected to grow significantly over the coming decade[2].

Projected Growth

The global pharmaceutical excipients market, including sodium benzoate, is projected to grow at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2034. By 2034, the market is expected to reach a valuation of USD 1,600.0 million[2][3].

Regional Growth

In the United States, the CAGR for the pharmaceutical excipients market is estimated to be 5.3% from 2024 to 2034, indicating robust growth in this region[2].

Market Segmentation and Competition

Market Segmentation

The pharmaceutical excipients market, including sodium benzoate, can be segmented based on type, technique, formulation, and application. This segmentation helps in understanding the diverse needs and trends within the market[2][4].

Competitive Landscape

The market is highly competitive, with established players like Ashland Global Holdings, Croda International, ADM, BASF SE, and Roquette Frères. These companies are expanding their portfolios and production facilities to meet growing demand and innovate in excipient development[2][3].

Regulatory and Cost Challenges

Regulatory Requirements

The pharmaceutical excipients market faces stringent regulatory requirements, which can act as a restraint. Compliance with these regulations can increase the cost of production and affect the overall market dynamics[4].

Cost of Production

The cost of producing sodium benzoate excipients is influenced by the prices of feedstock materials, production expenses, and logistical costs. These factors can fluctuate, impacting the profitability of manufacturers[1][4].

Opportunities and Future Outlook

Expansion in Emerging Markets

There is significant potential for growth in emerging markets, where the demand for pharmaceuticals and food products is increasing. Expanding into these markets can provide new opportunities for manufacturers of sodium benzoate excipients[4].

Development of New Formulations

The development of new and innovative formulations that incorporate sodium benzoate excipients can drive market growth. This includes advancements in drug delivery technologies and the creation of patient-friendly dosage forms[4].

Focus on Patient Compliance

An increased focus on patient compliance and the development of more effective drug formulations will continue to drive the demand for high-quality excipients like sodium benzoate[4].

"Several factors are driving the demand for innovative excipients in the pharmaceutical sector. The rise in chronic diseases such as diabetes, hypertension, cancer, and HIV necessitates the development of more effective and patient-friendly drug formulations."[3]

Key Takeaways

  • The demand for sodium benzoate excipients is driven by seasonal patterns, the growth of the pharmaceutical industry, and the need for effective preservatives in the food sector.
  • Supply chain disruptions, production costs, and geopolitical events significantly impact the market dynamics.
  • The pharmaceutical excipients market, including sodium benzoate, is expected to grow at a CAGR of 5.1% from 2024 to 2034.
  • The market faces regulatory and cost challenges but also presents opportunities for growth in emerging markets and through the development of new formulations.

FAQs

What are the primary drivers of demand for sodium benzoate excipients?

The primary drivers include seasonal demand patterns, the growth of the pharmaceutical industry, and the need for effective preservatives in the food sector.

How do supply chain disruptions affect the sodium benzoate excipient market?

Supply chain disruptions, such as transportation bottlenecks and geopolitical tensions, can increase costs and complicate logistics, contributing to price increases.

What is the projected growth rate of the pharmaceutical excipients market?

The market is expected to grow at a CAGR of 5.1% from 2024 to 2034.

Which companies are key players in the pharmaceutical excipients market?

Key players include Ashland Global Holdings, Croda International, ADM, BASF SE, and Roquette Frères.

What are the main challenges faced by the sodium benzoate excipient market?

The main challenges include regulatory requirements, the cost of production, and competition from alternative excipients.

Sources

  1. ChemAnalyst: Elevated Demand Underpins Persistent Price Rally in US Sodium Benzoate Excipient Market.
  2. Future Market Insights: Pharmaceuticals Excipients Market Size, Share & Trend by 2034.
  3. BCC Research: Understanding the Future of Pharmaceutical Excipients.
  4. Technavio: Understanding the Sodium Croscarmellose Excipient Market.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.